Showing results (191-200 of 532) with videos related to

Sort By:
Pageof 54
Drug Safety|March 1, 2020
Leveraging Human Genetics to Identify Safety Signals Prior to Drug Marketing Approval and Clinical UseRebecca N Jerome, Meghan Morrison Joly, Nan Kennedy, et al.
Circulation|October 9, 2014
Electrophysiologic substrate in congenital Long QT syndrome: noninvasive mapping with electrocardiographic imaging (ECGI)Ramya Vijayakumar, Jennifer N A Silva, Kavit A Desouza, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 4, 2003
The IKr drug response is modulated by KCR1 in transfected cardiac and noncardiac cell linesSabina Kupershmidt, Iris C-H Yang, Kenshi Hayashi, et al.
The American Journal of Cardiology|April 9, 2018
Clinical Features Associated With Nascent Left Ventricular Diastolic Dysfunction in a Population Aged 40 to 55 YearsJonathan D Mosley, Rebecca T Levinson, Evan L Brittain, et al.
Circulation|February 9, 2017
Age-Specific Trends in Incidence, Mortality, and Comorbidities of Heart Failure in Denmark, 1995 to 2012Mia N Christiansen, Lars Køber, Peter Weeke, et al.
Journal of the American Medical Informatics Association : JAMIA|September 25, 2020
PheMap: a multi-resource knowledge base for high-throughput phenotyping within electronic health recordsNeil S Zheng, QiPing Feng, V Eric Kerchberger, et al.
Heart (British Cardiac Society)|May 4, 2018
Increased long QT and torsade de pointes reporting on tamoxifen compared with aromatase inhibitorsVirginie Grouthier, Benedicte Lebrun-Vignes, Andrew M Glazer, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 29, 2004
In vivo identification of genes that modify ether-a-go-go-related gene activity in Caenorhabditis elegans may also affect human cardiac arrhythmiaChristina I Petersen, Toni R McFarland, Svetlana Z Stepanovic, et al.
Pageof 54